Table 3:
ANOVA results from Changes in LVEF overtime by QRS group
| Unadjusted | Adjusted* | |||||
|---|---|---|---|---|---|---|
| Mean Change | Effect Estimate (95% CI) | ANOVA P-Value | LS Mean Change | Effect Estimate (95% CI) | ANOVA P-Value | |
| LBBB | 3.41 (±9.43) | - | <0.0001 | 2.03 (±13.59) | - | <0.0001 |
| WQRS | 4.86 (±9.22) | 1.45 (2.19 to 5.09) | 5.28 (±12.62) | 3.25 (−0.26 to 6.75) | ||
| NQRS | 9.50 (±12.17) | 6.08 (3.71 to 8.46) | 8.00 (±21.55) | 5.97 (3.62 to 8.31) | ||
| Tukey Multiple Comparison Adjusted Analyses | ||
|---|---|---|
| Comparison | Unadjusted Tukey P-Value | Adjusted Tukey P-Value |
| LBBB vs. NQRS | <0.0001 | <0.0001 |
| LBBB vs. WQRS | 0.7145 | 0.1636 |
| NQRS vs. WQRS | 0.0101 | 0.1672 |
Adjusted for: Baseline LVEF, GDMT, History of Atrial Fibrillation/Flutter, Age, Gender, History of Cerebrovascular Disease, Prior Myocardial Infarction, Baseline Heart Rate on ECG, History and Duration of Heart Failure, and Left Atrium Size; One patient excluded due to missing Heart Rate.